Cargando…
Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
INTRODUCTION: Systematic documentation of chemotoxicities in outpatient clinics is challenging. Incorporating patient-reported outcome (PRO) measures in clinical workflows can be an efficient strategy to strengthen the assessment of symptomatic treatment toxicities in oncology clinical practice. We...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360011/ https://www.ncbi.nlm.nih.gov/pubmed/32700029 http://dx.doi.org/10.1007/s40487-018-0065-7 |
_version_ | 1783559152791977984 |
---|---|
author | Wang, Tian Qi Samuel, Joseph N. Brown, M. Catherine Vennettilli, Ashlee Solomon, Hannah Eng, Lawson Liang, Mindy Gill, Gursharan Merali, Zahra Tian, Chenchen Cheng, Nicholas Y. H. Campbell, Matthew Patel, Devalben Liu, Ai Xin Liu, Geoffrey Howell, Doris |
author_facet | Wang, Tian Qi Samuel, Joseph N. Brown, M. Catherine Vennettilli, Ashlee Solomon, Hannah Eng, Lawson Liang, Mindy Gill, Gursharan Merali, Zahra Tian, Chenchen Cheng, Nicholas Y. H. Campbell, Matthew Patel, Devalben Liu, Ai Xin Liu, Geoffrey Howell, Doris |
author_sort | Wang, Tian Qi |
collection | PubMed |
description | INTRODUCTION: Systematic documentation of chemotoxicities in outpatient clinics is challenging. Incorporating patient-reported outcome (PRO) measures in clinical workflows can be an efficient strategy to strengthen the assessment of symptomatic treatment toxicities in oncology clinical practice. We compared the adequateness, feasibility, and acceptability of toxicity documentation using systematic, prospective, application of the PRO Common Toxicity Criteria for Adverse Events (PRO-CTCAE) tool. METHODS: At a comprehensive cancer center, data abstraction of electronic health record reviews elucidated current methods and degree of chemotoxicity documentation. Web-based 32-item PRO-CTCAE questionnaires, administered in ambulatory clinics of patients receiving chemotherapy, captured chemotoxicities and respective severities. Patient telephone surveys assessed whether healthcare providers had addressed chemotoxicities to the patients’ satisfaction. RESULTS: Over a broad demographic of 497 patients receiving chemotherapy, 90% (95% CI 84–96%) with significant chemotoxicities (n = 107) reported that their providers had discussed toxicities with them; of these, 70% received a therapy management change, while among the rest, 17% desired a change in management. Of patients surveyed, 91% (95% CI 82–99%) were satisfied with their current chemotoxicity management. Clinician chart documentation varied greatly; descriptors rather than numerical grading scales were typically used. Although 93% of patients were willing to complete the PRO survey, only 50% thought that it would be acceptable to complete this survey at routine clinic visits. CONCLUSION: Use of PRO-CTCAE in routine clinical practice promotes systematic evaluation of symptomatic toxicities and improves the clarity, consistency, and efficiency of clinician documentation; however, methods to improve patient willingness to complete this tool routinely are needed. |
format | Online Article Text |
id | pubmed-7360011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-73600112020-07-20 Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Wang, Tian Qi Samuel, Joseph N. Brown, M. Catherine Vennettilli, Ashlee Solomon, Hannah Eng, Lawson Liang, Mindy Gill, Gursharan Merali, Zahra Tian, Chenchen Cheng, Nicholas Y. H. Campbell, Matthew Patel, Devalben Liu, Ai Xin Liu, Geoffrey Howell, Doris Oncol Ther Original Research INTRODUCTION: Systematic documentation of chemotoxicities in outpatient clinics is challenging. Incorporating patient-reported outcome (PRO) measures in clinical workflows can be an efficient strategy to strengthen the assessment of symptomatic treatment toxicities in oncology clinical practice. We compared the adequateness, feasibility, and acceptability of toxicity documentation using systematic, prospective, application of the PRO Common Toxicity Criteria for Adverse Events (PRO-CTCAE) tool. METHODS: At a comprehensive cancer center, data abstraction of electronic health record reviews elucidated current methods and degree of chemotoxicity documentation. Web-based 32-item PRO-CTCAE questionnaires, administered in ambulatory clinics of patients receiving chemotherapy, captured chemotoxicities and respective severities. Patient telephone surveys assessed whether healthcare providers had addressed chemotoxicities to the patients’ satisfaction. RESULTS: Over a broad demographic of 497 patients receiving chemotherapy, 90% (95% CI 84–96%) with significant chemotoxicities (n = 107) reported that their providers had discussed toxicities with them; of these, 70% received a therapy management change, while among the rest, 17% desired a change in management. Of patients surveyed, 91% (95% CI 82–99%) were satisfied with their current chemotoxicity management. Clinician chart documentation varied greatly; descriptors rather than numerical grading scales were typically used. Although 93% of patients were willing to complete the PRO survey, only 50% thought that it would be acceptable to complete this survey at routine clinic visits. CONCLUSION: Use of PRO-CTCAE in routine clinical practice promotes systematic evaluation of symptomatic toxicities and improves the clarity, consistency, and efficiency of clinician documentation; however, methods to improve patient willingness to complete this tool routinely are needed. Springer Healthcare 2018-10-22 /pmc/articles/PMC7360011/ /pubmed/32700029 http://dx.doi.org/10.1007/s40487-018-0065-7 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Wang, Tian Qi Samuel, Joseph N. Brown, M. Catherine Vennettilli, Ashlee Solomon, Hannah Eng, Lawson Liang, Mindy Gill, Gursharan Merali, Zahra Tian, Chenchen Cheng, Nicholas Y. H. Campbell, Matthew Patel, Devalben Liu, Ai Xin Liu, Geoffrey Howell, Doris Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) |
title | Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) |
title_full | Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) |
title_fullStr | Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) |
title_full_unstemmed | Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) |
title_short | Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) |
title_sort | routine surveillance of chemotherapy toxicities in cancer patients using the patient-reported outcomes version of the common terminology criteria for adverse events (pro-ctcae) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360011/ https://www.ncbi.nlm.nih.gov/pubmed/32700029 http://dx.doi.org/10.1007/s40487-018-0065-7 |
work_keys_str_mv | AT wangtianqi routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT samueljosephn routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT brownmcatherine routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT vennettilliashlee routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT solomonhannah routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT englawson routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT liangmindy routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT gillgursharan routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT meralizahra routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT tianchenchen routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT chengnicholasyh routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT campbellmatthew routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT pateldevalben routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT liuaixin routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT liugeoffrey routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae AT howelldoris routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae |